For monoblasts, reduced SSEA-1 and SSEA-3 expression was observed in AML M4/M5 samples compared to normal samples, whereas CD34+ myeloblasts from AML M4/M5 samples expressed more SOX2 than their normal counterparts. The gene discussed is SOX2; the disease is acute myeloid leukemia.